-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37

PUBT·07/29/2026 20:05:54
Listen to the news
Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37
  • Rapport Therapeutics CEO Abraham Ceesay sold 2,210 common shares on July 27, 2026.
  • Sales priced at USD 42.11 and USD 42.74.
  • Direct holdings fell to 537,607 shares following the transactions.
  • Form also reported 81,729 shares held by the Ceesay Family Irrevocable Trust, 20,729 shares held by the Dorothy Ceesay Irrevocable Trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-323637), on July 29, 2026, and is solely responsible for the information contained therein.